5-Amino-1MQ

5-Amino-1MQ Metabolic & Systemic Energy Profile

5-Amino-1MQ is fundamentally integrated into the modulation of mammalian metabolism, forcing biological networks toward lipolysis, enhanced ATP synthesis, and profound systemic energy mobilization.

Pharmacological Architecture

Parameter	Value
Molecular Formula	C10H10N2O
Molecular Mass	174.2 g/mol
Assay Purity	>99.0%
Appearance	Yellowish crystalline powder

Figure 1: Cellular Action of 5-Amino-1MQ

Metabolic Transduction Pattern

Detailed cascade of actions governing its systemic thermogenic profile:

1. Functions as a direct, highly potent and selective inhibitor of the NNMT enzyme.
2. Halts the NNMT-induced conversion and depletion of critical NAD+ molecules.
3. Flood cell mitochondria with raw, unrestrained NAD+, reversing metabolic slowing.
4. Reverses diet-induced obesity immediately by crushing fat cell survival signals.
5. Reduces cellular fat volume and drives extreme, localized non-shivering thermogenesis.

Figure 2: Rate of Systemic Lipolysis & Output

Primary Research Results

• Outcome 1: One of the only small-molecule modalities proven to physically shrink existing white fat cells.
• Outcome 2: Does not cross the blood-brain barrier, providing massive metabolic drive without CNS stimulation.
• Outcome 3: Dramatically enhances skeletal muscle contraction efficiency in addition to lipolysis.

NNMT Inhibition & Metabolic Reprogramming

5-Amino-1-methylquinolinium (5-Amino-1MQ) is a small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme increasingly recognized as a key regulator of cellular energy metabolism and fat storage. NNMT catalyzes the methylation of nicotinamide to 1-methylnicotinamide, consuming S-adenosylmethionine (SAM) in the process. This reaction sits at a critical metabolic intersection: it simultaneously depletes the NAD+ salvage pathway (by diverting nicotinamide) and the methyl donor pool (by consuming SAM), linking it to epigenetic regulation, energy homeostasis, and adipogenesis.

1. NNMT is highly expressed in white adipose tissue, where it promotes adipocyte differentiation and lipid accumulation by depleting SAM-dependent histone methylation marks that suppress adipogenic genes.
2. 5-Amino-1MQ competitively inhibits NNMT, preserving intracellular nicotinamide for NAD+ biosynthesis via the salvage pathway (NAMPT → NMN → NAD+).
3. Elevated NAD+ activates SIRT1 (a NAD+-dependent deacetylase), which deacetylates PPARγ and suppresses adipogenic transcription programs.
4. SAM levels are simultaneously preserved, maintaining the histone methylation patterns that keep adipogenic gene promoters in a repressed state.
5. The net effect is reduced adipocyte differentiation, increased fatty acid oxidation, and improved cellular energy metabolism.

Research Evidence & Applications

• Diet-Induced Obesity: In high-fat diet mouse models, 5-Amino-1MQ reduced body weight and total fat mass without affecting food intake, indicating metabolic rather than anorectic mechanisms.
• Adipocyte Size: Treated mice showed significantly smaller adipocytes and reduced crown-like structures (markers of adipose inflammation) on histological analysis.
• Muscle Metabolism: NNMT inhibition in skeletal muscle increases NAD+ availability, enhancing mitochondrial respiration and exercise capacity in preclinical models.
• Oral Bioavailability: 5-Amino-1MQ is a small molecule (MW 173.2 Da) with favorable oral pharmacokinetics, unlike peptides that require injection.
• Cancer Research: NNMT overexpression is observed in multiple cancers; 5-Amino-1MQ is being investigated as an adjunctive metabolic therapy in oncology research.